"“Salicylic acid is one of the oldest drugs on the planet, dating back to the Egyptians and the Greeks, but we’re still discovering new things about it,” said senior author Eric Verdin, MD, associate director of the Gladstone Institute of Virology and Immunology. “Uncovering this pathway of inflammation that salicylic acid acts upon opens up a host of new clinical possibilities for these drugs.”"
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity